Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Chubb
US Department of Justice
Argus Health
Julphar
US Army
QuintilesIMS
Daiichi Sankyo
Moodys
Novartis

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017447

« Back to Dashboard

NDA 017447 describes NORPACE, which is a drug marketed by Gd Searle Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the NORPACE profile page.

The generic ingredient in NORPACE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
Summary for 017447
Tradename:NORPACE
Applicant:Gd Searle Llc
Ingredient:disopyramide phosphate
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 017447
Medical Subject Heading (MeSH) Categories for 017447
Suppliers and Packaging for NDA: 017447
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORPACE disopyramide phosphate CAPSULE;ORAL 017447 NDA G.D. Searle LLC Division of Pfizer Inc 0025-2752 0025-2752-52 1000 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2752-52)
NORPACE disopyramide phosphate CAPSULE;ORAL 017447 NDA G.D. Searle LLC Division of Pfizer Inc 0025-2752 0025-2752-31 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2752-31)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 100MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 150MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
Boehringer Ingelheim
Farmers Insurance
Colorcon
Merck
Express Scripts
Fish and Richardson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot